chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bronchitis; COVID-19; Bad cough; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis), COVID-19 (COVID-19) and COUGH (Bad cough) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BRONCHITIS (Bronchitis), COVID-19 (COVID-19) and COUGH (Bad cough). The patient was treated with AZITHROMYCIN (ZITHROMAX) at an unspecified dose and frequency; DEXAMETHASONE at an unspecified dose and frequency and BENZONATATE at an unspecified dose and frequency. At the time of the report, BRONCHITIS (Bronchitis), COVID-19 (COVID-19) and COUGH (Bad cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medications were provided. Treatment medications included Supplements. Action taken with mRNA-1273 in response to the events was not applicable.
Headache, Myalgia & Fever Narrative: EMPLOYEE STATED TOOK OTC TYLENOL WITH IMPROVEMENT IN SYMPTOMS
Red, raised welts appeared on left cheek of face - did not itch - were actually noticed by a co-worker - still slightly apparent on 11-2-09 - still light pink and just slightly raised
Information has been received from a registered nurse concerning a child who recently, in approximately April 2006, was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live.  In approximately April 2006, the patient experienced a fever equal to or greater than 102 degrees Fahrenheit.  A product quality complaint was involved.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements and was releases.  Additional information has been requested.
Experiencing vertigo for the first time in 15 years- dizziness, loss of balance, nausea and vomiting, excessive exhaustion.  Tinnitus is getting worse.
FEVER; CHILLS; HEADACHE; DIZZINESS; MUSCLE ACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch no was not reported and has been requested. No concomitant medications were reported. On 06-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced chills. On 06-APR-2021, the subject experienced headache. On 06-APR-2021, the subject experienced dizziness. On 06-APR-2021, the subject experienced muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, headache, dizziness, and muscle ache. This report was non-serious.
Information has been received from a physician concerning a 12 month old white female with no allergies or medical conditions who on 03May05 was vaccinated SC in the left arm with a first dose of varicella virus vaccine live (lot649276/0898P). There was no concomitant medication and no illness at the time of vaccination. It was noted that she recently, in May 2005, developed a rash described as some bumps that were red and then blistered on the face. Unspecified medical attention was sought but no labs or diagnostic tests were done. On an unk date the pt recovered. Additional information is not expected.
A male patient in his mid-50's, diagnosed with Transitional Cell Carcinoma of the Bladder in late December 2002, with transurethral resection of bladder tumor, received an initial treatment of Tice BCG on approximately 01/20/2003.  It was the first of a planned series of a 6 weekly instillations.  Following this one, the patient began experiencing chills intermittently, lasting 1-2 days, and also "severe burning with urination" and "suprapubic bladder pressure all the time", both of which continued to persist severely 10-11 days later, at the time of the report.  Due to the severity of the patient's symptoms, he did not receive any further BCG therapy.  No further treatment.
Sever abdominal pain that started 1/21 at 9pm. Persisted overnight. Went to ER at 930am on 1/22. Diagnosed with appendicitis. Appendectomy surgery performed around 7pm on 1/22/21.
Muscle soreness/stiffness to the point where he couldn't lift his arm. Went away for about 1 week then came back and still cannot raise left arm. Flu shot was administered about 1 month ago.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 11:41 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 11:41 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient age was reported as 64.71 years. No concomitant product use was reported. It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34- or 35-degree F.  On 11-Jan-2021, Excursion temperature at 09 am was 34, at 2 pm was 35, total doses given for the day was 98, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 05-Jan-2021 and 08-Jan-2021, vial was moved to clinic on 08-Jan-2021 and 11-Jan-2021. 2 and 9 vials was moved to clinic. Vaccine BUD date was 04-Feb-2021 and 07-Feb-2021 for batch 041L20A.  Temperature recordings were taken by using a  traceable temperature monitor at every hour. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided.
lt arm swollen, red, painful to touch, 36hr post vax;tx ice, APAP PRN;
Moderate pain in left arm from shoulder to finger tips. Lymph nodes, under left arm and across collar bone, across left ribs and down to left elbow extremely swollen and painful. Was seen by MD on 4/26/01 and dx'd with lymphedema and an infection of cellulite tissue from bacteria in multi-dose vial. Seen by private physician.
Itching started on waist . Rash on 04/22/2022. Diagnosed with shingles on 04/25/3021 via telehealth doctor.
Had hoarseness, fever and fast heart beat. Doing much better now. Fever accelerated heart beat, hoarseness, and slight fatigue. She was treated at home with Children's Motrin. Per follow up, Pt had reaction to Polio vaccination.
The information has been received from a mother concerning her 15 year old daughter, with no pertinent medical history, or known drug allergies/drug reactions who on 18-JUL-2008 was vaccinated with her "first dose" of GARDASIL vaccine.  There was no concomitant medications.  The mother reported that approximately "3 - 4 weeks after vaccination" her daughter experienced alopecia.  It was reported that her hair was starting to slowly grow back.  "Unspecified tests" were performed (results not provided).  The patient did not plan on receiving her second or third dose.  At the time of this report, the patient was recovering.  The patient sought medical attention.  No further information is available.
This spontaneous case reported by a consumer, describes the occurrence of arthralgia (joint pain), increased international normalised ratio (INR spiked to 9), decreased international normalised ratio (INR gone down to 5), joint swelling (slight swelling in wrist) and peripheral swelling (slight swelling in fingers) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced arthralgia (joint pain), increased international normalised ratio (INR spiked to 9), decreased international normalised ratio (INR gone down to 5), joint swelling (slight swelling in wrist) and peripheral swelling (slight swelling in fingers). At the time of the report, arthralgia (joint pain), increased international normalised ratio (INR spiked to 9), decreased international normalised ratio (INR gone down to 5), joint swelling (slight swelling in wrist) and peripheral swelling (slight swelling in fingers) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments.
Tiredness after the shots and slight fever (was told that would be normal after the shots) she passed away the next day.
The client received her IM vaccine without incident.  Shortly after standing, she felt dizzy and immediately fainted.  She regained consciousness within 10 seconds.  Vital signs stable.  Alert and oriented x3.
Distal rxn given in lt deltoid IM; burn like area lt elbow size 1/2 dollar-heat w/swelling from elbow inc 3-4 in w/elevated temp on noc of 27FEB92; t102 x 48 hrs;
extreme dizziness/ got extremely dizzy; caused a fall, when in the shower.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): PFIZER INC-202101367174 (Pfizer).  A 62 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Mar2021 (Batch/Lot number: unknown) at the age of 61 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Arachnoid cyst" (ongoing), notes: arachnoid cyst on the brain, 20-25 years ago. There were no concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 15Mar2021 14:00, outcome "recovered" (Mar2021), described as "extreme dizziness/ got extremely dizzy"; FALL (non-serious) with onset 15Mar2021, outcome "unknown", described as "caused a fall, when in the shower.". The event "extreme dizziness/ got extremely dizzy" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Patient 20-25 years ago had an arachnoid cyst on his brain and they always kept an eye on it but maybe this was making him dizzy and it was 20-25 years ago and nothing came from it but it was a spot on his brain that was nothing. Vaccination Facility Type was Park. The patient has not received any other vaccines within 4 weeks prior to vaccination. No Additional Vaccines Administered on Same Date of the Pfizer Suspect. No relevant Family Medical History. The patient on 15Mar2021 at 1400 in the afternoon, got out of bed and the dizziness started and caused a fall, when in the shower and woke up the next morning. He experienced extreme dizziness which lasted three weeks. He was scared, so he did not get the second dose. He does want to get the second dose, as he believes in science. He also said that his general doctor has no clue. No Emergency Room visit. The reporter states he just went to his primary care physician and an ENT and they just did an Emply manuver and he really wants the 2nd dose of the Pfizer Covid vaccine but it scared him so much and he never went for the 2nd shot and it may be a coincidence that happened but it affected him so badly. Patient didn't know if it is normal what he experienced or an allergic reaction, He has no antibodies in him, he did the bloodwork. He wants to be protected. He knows the second dose needs to be given 21 to 30 days after the first, and his General Practitioner doesn't know what he should do. He wishes that someone would let him know what to do. For now, he will keep wearing his mask and get a flu shot. Dizziness has now completely resolved but he does not know when it resolved.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Itching / Soreness of right breast. Started about 1 hour after vaccination and continued for approximately 48 hours.
Swelling in back of knee; its hard to stand; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swelling in back of knee) and DYSSTASIA (its hard to stand) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced JOINT SWELLING (Swelling in back of knee) and DYSSTASIA (its hard to stand). At the time of the report, JOINT SWELLING (Swelling in back of knee) and DYSSTASIA (its hard to stand) had not resolved.     Patient reported non-drug treatment for symptoms included Heat and TENS unit. Concomitant product use was not provided by the reporter.
Client with a history of anxiety complaining of chest pain. EMS Eval. EMS advised transport, client accepted.
Panicking because does not see a time listed of when supposed to go get second dose tomorrow; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Lot number: EW0158) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PANIC REACTION (non-serious) with onset May2021, outcome "unknown", described as "Panicking because does not see a time listed of when supposed to go get second dose tomorrow".  Additional information: She is scheduled to get her second dose tomorrow, but she does not have a time listed and she is panicking. She is wondering what to do, what she is supposed to do. She does not see a second does appointment time on the paper either she received.   No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a physician refers to a current 13 years old female patient without pertinent medical history. The patient was vaccinated with 0.5 ml unspecified dose of GARDASIL (lot number not provided) in approximately September 2010, "2 years ago". No other co-suspects were reported. No concomitant medications were reported. In approximately September 2010, "2 years ago", when the patient was 11 years old, she was given GARDASIL, and afterwards she fainted, fell down and broke her elbow. She was sent to the ER but was not admitted. The patient had sought unspecified medical attention. Adverse events improved after stopping therapy. The outcome of broke her elbow, fainted and fell down was reported as recovered in approximately September 2010, "2 years ago". Additional information has been requested.
Pizer Pediatric vaccine 5-11 yr old formulation given to a 4 year old child in error.
pt exp 2 siezures beginning 24MAr93 first one ocurring during feeding, second in hospital; t99; discharged w/no specific instructions or meds;
Hot, itching ears outside and inside starting at 4:00pm. Followed by itchy mouth, racing heart, and all over skin itching. I took an extra Claritin at about 4:15. Then around 5pm I had a sudden feeling of an allover body sensation like a surge of electricity or drop in blood pressure, and had ringing in my ears and slowing of thoughts and movement and awareness. Went to the ER. Still itchy and ears were red. About 2 hours later all itching was gone and ears were no longer red. Stayed at the ER until 7:40pm.
Fever, chills, severe body aches, severe headache, fatigue. Slept 36 hours- full body rash.
Rash shingles onset 6/17/2021. Fever started 6/20/2021, headache started 6/19/2021. Seen by pediatrician 6/21/2021. Negative Covid and negative strep test. Diagnosis: shingles
she is currently experiencing itchy eyes and she said that it looks like its swelling.; she is currently experiencing itchy eyes and she said that it looks like its swelling.; This is a spontaneous report from a Pfizer (Patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on 17Mar2021 as dose 1, single for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient experienced she is currently experiencing itchy eyes and she said that it looks like its swelling. on an unspecified date. She wanted to know if it is part of the reactions of the vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
Previously well woman with no history of knee arthritis or dermatitis. 13 days after vaccine administration, began to experience myalgias, arthralgias (especially knees, shoulders), fatigue, conjunctival injection, papular rash to L arm>trunk and other extremities. Day 17 after vaccine, seen in ED for above symptoms with neg COVID, HIV, Hepatitis testing. Day 21 after vaccine, seen again in office with persistent arthralgias, noted to have ESR and CRP elevated, returning to normal by 34 days after vaccine. Seen by me on day 47 after vaccination with persistent fatigue, mental fog, and arthralgias in knees.
Headache, joint pain, malaise, fatigue, difficulty walking, can?t think clearly.
first syringe used malfunctioned; chest tightness; nausea; dizziness; It therefore seems likely that I did receive some of the first vaccine and therefore was injected with a higher dose than recommended; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest tightness), NAUSEA (nausea), DIZZINESS (dizziness), OVERDOSE (It therefore seems likely that I did receive some of the first vaccine and therefore was injected with a higher dose than recommended) and SYRINGE ISSUE (first syringe used malfunctioned ) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 on 23-Dec-2022. Previously administered products included for COVID-19 prophylaxis: Moderna vaccines. Past adverse reactions to the above products included No adverse event with Moderna vaccines.   On 15-Nov-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On 15-Nov-2023, received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) dosage was changed to 1 dosage form. On 15-Nov-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced OVERDOSE (It therefore seems likely that I did receive some of the first vaccine and therefore was injected with a higher dose than recommended). On 16-Nov-2023, the patient experienced CHEST DISCOMFORT (chest tightness), NAUSEA (nausea) and DIZZINESS (dizziness). On an unknown date, the patient experienced SYRINGE ISSUE (first syringe used malfunctioned ). At the time of the report, CHEST DISCOMFORT (chest tightness), NAUSEA (nausea) and DIZZINESS (dizziness) had not resolved and OVERDOSE (It therefore seems likely that I did receive some of the first vaccine and therefore was injected with a higher dose than recommended) and SYRINGE ISSUE (first syringe used malfunctioned ) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  It was reported that the first syringe used malfunctioned, and it was unclear how much of the vaccine was transmitted. The provider switched arms and administered a full dose of a second vaccine. The provider assured that none or 'little' of the first vaccine was transmitted. Since the vaccination the patient had significant side effects - chest tightness, ongoing nausea, dizziness, that were never experienced with previous Moderna covid vaccines. The patient thought she likely received some of the first vaccine and therefore was injected with a higher dose than recommended. The patient did not experience any additional symptoms/events.  Treatment medication was not reported.
Pfizer 3/1/21, 3/22/21, 11/15/21, 7/21/22. Positive on 1/31/23
Pt. received ZOSTAVAX inj 10-23-14. Pt. called 10/27/14 c/o - "A welt" at inject site, headache, itching at inj site and slight shortness of breath.
Within a few hours my left should joint started to hurt.   Within 8 hours I was in extreme pain and could not move my left arm.  Any movement of my left arm resulted in strong stabbing pain in my shoulder.  After three days it improved and after one week it was completely gone.  The AE reminded me of calcific tendonitis flare up which I have in both shoulders.  I went to urgent care as I could not sleep due to pain and they told me to wait a few days and take OTC pain meds.
Patient developed Shingles; This spontaneous case was reported by an other caregiver and describes the occurrence of HERPES ZOSTER (Patient developed Shingles) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. #042B21A and 028A21H) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HERPES ZOSTER (Patient developed Shingles). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALACICLOVIR RANBAXY) at a dose of 1 dosage form. At the time of the report, HERPES ZOSTER (Patient developed Shingles) outcome was unknown. Not Provided
Pain and Muscle weakness in left arm and shoulder.  Pulsating throbbing pain in left Deltoid and Shoulder.  Aleve not effective for pain relief. Pain scale 7/10.
Information received from physician. Pt post vaccine experienced a generalized petechial rash on the neck and trunk.